Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial.
Desideri A, Fioretti PM, Cortigiani L, Trocino G, Astarita C, Gregori D, Bax J, Velasco J, Celegon L, Bigi R, Pirelli S, Picano E. Desideri A, et al. Among authors: bax j. Heart. 2005 Feb;91(2):146-51. doi: 10.1136/hrt.2003.026849. Heart. 2005. PMID: 15657220 Free PMC article. Clinical Trial.
Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction.
Desideri A, Fioretti PM, Cortigiani L, Gregori D, Coletta C, Vigna C, Tota F, Rambaldi R, Bax J, Celegon L, Bigi R, Picano E; COSTAMI (Cost of Strategies After Myocardial Infarction) Trial Investigators. Desideri A, et al. Among authors: bax j. Eur Heart J. 2003 Sep;24(18):1630-9. doi: 10.1016/s0195-668x(03)00308-7. Eur Heart J. 2003. PMID: 14499225 Clinical Trial.
Simplifying coronary artery disease risk stratification: development and validation of a questionnaire-based alternative comparable to clinical risk tools.
Kokkorakis M, Folkertsma P, Anagnostakis F, Sirotin N, Agarwal M, Shantouf R, Henning RH, Pijl H, Wolffenbuttel BHR, Bax JJ, Atsma DE, Castela Forte J, Mantzoros CS, van Dam S. Kokkorakis M, et al. Among authors: bax jj. EBioMedicine. 2024 Dec 24;111:105518. doi: 10.1016/j.ebiom.2024.105518. Online ahead of print. EBioMedicine. 2024. PMID: 39724785 Free article.
Prognostic Implications of Right Ventricular Dysfunction in Severe Degenerative Mitral Regurgitation.
Bohbot Y, Essayagh B, Benfari G, Bax JJ, Le Tourneau T, Topilsky Y, Antoine C, Rusinaru D, Grigioni F, Ajmone Marsan N, van Wijngaarden A, Hochstadt A, Roussel JC, Diouf M, Thapa P, Michelena HI, Enriquez-Sarano M, Tribouilloy C. Bohbot Y, et al. Among authors: bax jj. J Am Heart Assoc. 2025 Jan 7;14(1):e036206. doi: 10.1161/JAHA.124.036206. Epub 2024 Dec 18. J Am Heart Assoc. 2025. PMID: 39692024 Free article.
Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer.
Martens ESL, Becker D, Abele C, Abbel D, Achterberg WP, Bax JJ, Bertoletti L, Edwards ME, Font C, Gava A, Goedegebuur J, Højen AA, Huisman MV, Kruip MJHA, Mahé I, Mooijaart SP, Pearson M, Seddon K, Szmit S, Noble SIR, Klok FA, Konstantinides SV. Martens ESL, et al. Among authors: bax jj. Thromb Res. 2025 Jan;245:109205. doi: 10.1016/j.thromres.2024.109205. Epub 2024 Nov 9. Thromb Res. 2025. PMID: 39667100 Free article.
2,228 results